Advanced company searchLink opens in new window

GAMMA BIOSCIENCES HOLDCO LIMITED

Company number 12558722

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
01 May 2024 CS01 Confirmation statement made on 15 April 2024 with updates
15 Apr 2024 PSC05 Change of details for Gamma Biosciences Bidco Limited as a person with significant control on 15 April 2024
05 Apr 2024 AD01 Registered office address changed from 11th Floor 200 Aldersgate Street London EC1A 4HD United Kingdom to Duo, Level 6 280 Bishopsgate London EC2M 4RB on 5 April 2024
14 Sep 2023 SH19 Statement of capital on 14 September 2023
  • USD 41,211,388.69
14 Sep 2023 SH20 Statement by Directors
14 Sep 2023 CAP-SS Solvency Statement dated 14/09/23
14 Sep 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 14/09/2023
08 Sep 2023 AA Total exemption full accounts made up to 31 December 2022
11 Jul 2023 AP01 Appointment of Mr Eric Simpson as a director on 22 June 2023
11 Jul 2023 TM01 Termination of appointment of Kugan Sathiyanandarajah as a director on 21 June 2023
11 Jul 2023 TM01 Termination of appointment of Anogie Joseph-Erameh as a director on 21 June 2023
09 Jun 2023 SH01 Statement of capital following an allotment of shares on 31 May 2023
  • USD 41,211,388.69
27 Apr 2023 CS01 Confirmation statement made on 15 April 2023 with no updates
03 Jan 2023 AA Total exemption full accounts made up to 31 December 2021
23 May 2022 AA Total exemption full accounts made up to 31 December 2020
20 Apr 2022 CS01 Confirmation statement made on 15 April 2022 with updates
22 Nov 2021 SH01 Statement of capital following an allotment of shares on 20 September 2020
  • USD 32,625,994.78
22 Nov 2021 SH01 Statement of capital following an allotment of shares on 6 January 2021
  • USD 38,440,254.78
22 Nov 2021 SH01 Statement of capital following an allotment of shares on 2 June 2021
  • USD 41,211,388.65
20 Apr 2021 CS01 Confirmation statement made on 15 April 2021 with updates
13 Jul 2020 SH01 Statement of capital following an allotment of shares on 8 July 2020
  • USD 24,121,283.99
07 Jul 2020 AP01 Appointment of Mr Anogie Joseph-Erameh as a director on 7 July 2020
07 Jul 2020 TM01 Termination of appointment of Bjorn Clauber Ruwald as a director on 7 July 2020
24 Jun 2020 TM01 Termination of appointment of Steven James Burton as a director on 23 June 2020
13 May 2020 AA01 Current accounting period shortened from 30 April 2021 to 31 December 2020